| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.4M | +31.5% |
| Cost of Revenue | $6.9M | +16.4% |
| Gross Profit | $4.5M | +64.1% |
| R&D Expense | $2K | -97.4% |
| SG&A Expense | $7.9M | +26.3% |
| Operating Income | -$3.4M | +5.7% |
| Pre-tax Income | -$2.9M | +16.5% |
| Net Income | -$3.0M | +8.6% |
| EPS (Basic) | -$0.38 | +24.0% |
| EPS (Diluted) | -$0.38 | +24.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $673K | -27.9% |
| Inventory | $2.1M | +20.6% |
| Current Assets | $4.3M | -15.2% |
| Total Assets | $10.5M | -4.8% |
| Current Liabilities | $3.0M | +19.7% |
| Long-term Debt | $588K | -14.2% |
| Total Liabilities | $5.6M | +13.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | +66.1% |
| Capital Expenditures | $68K | -84.7% |
| Investing Cash Flow | -$68K | +91.2% |
| Financing Cash Flow | $630K | -83.2% |
| Free Cash Flow | -$1.4M | +68.0% |
| $4.5M |
| -22.5% |